Sapkota GP et al. |
Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth. |
2001 |
J. Biol. Chem. |
pmid:11297520
|
Sharkey TD et al. |
Isoprene increases thermotolerance of fosmidomycin-fed leaves. |
2001 |
Plant Physiol. |
pmid:11299379
|
|
|
|
|
pmid:11305090
|
Jagdev SP et al. |
The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. |
2001 |
Br. J. Cancer |
pmid:11308265
|
Houten SM et al. |
Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. |
2001 |
Eur. J. Hum. Genet. |
pmid:11313768
|
Skaletz-Rorowski A et al. |
Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition. |
2001 |
Eur. J. Cell Biol. |
pmid:11322384
|
Takemoto M et al. |
NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells. |
2001 |
Br. J. Pharmacol. |
pmid:11325797
|
|
|
|
|
pmid:11336263
|
MartÃnez-González J et al. |
3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulation. |
2001 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11348878
|
O'Neill FH et al. |
Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. |
2001 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11348882
|
Chang JJ et al. |
The in vitro inhibitory effect of tannin derivatives on 3-hydroxy-3-methylglutaryl-coenzyme a reductase on vero cells. |
2001 |
Pharmacology |
pmid:11359999
|
|
|
|
|
pmid:11371670
|
Stalker TJ et al. |
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. |
2001 |
Br. J. Pharmacol. |
pmid:11375257
|
Raicht RF et al. |
Sterol balance studies in the rat. Effects of dietary cholesterol and beta-sitosterol on sterol balance and rate-limiting enzymes of sterol metabolism. |
1975 |
Biochim. Biophys. Acta |
pmid:1137717
|
|
|
|
|
pmid:11379812
|
Scoppola A et al. |
Urinary mevalonate excretion rate in type 2 diabetes: role of metabolic control. |
2001 |
Atherosclerosis |
pmid:11395032
|
|
|
|
|
pmid:11397393
|
Yasunari K et al. |
HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. |
2001 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11397700
|
Wong B et al. |
Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation. |
2001 |
J. Leukoc. Biol. |
pmid:11404382
|
Shukolyukov SA and Saakov VS |
American cockroach (Periplaneta americana) synthesizes carotenoids from the precursor. |
2001 |
Biochemistry Mosc. |
pmid:11405890
|